1,7-phenanthroline has been researched along with Atherosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, R; Liang, RX; Liu, HL; Wang, JL; Wang, L; Wang, WD; Yan, RY; Yang, B; Yang, HJ; Zhang, JY | 1 |
Cao, Y; Chen, WN; Feng, JY; Jia, LQ; Lei, P; Li, XT; Ren, L; Yang, GL; Zhang, L | 1 |
2 other study(ies) available for 1,7-phenanthroline and Atherosclerosis
Article | Year |
---|---|
[Experimental study on anti-atherosclerotic effect of compatibility of active components of danshen and shanzha].
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Drugs, Chinese Herbal; Endothelium, Vascular; Lipids; Male; Phenanthrolines; Phytotherapy; Rats; Salvia miltiorrhiza | 2013 |
Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells.
Topics: Abietanes; Antioxidants; Apoptosis; Atherosclerosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Drugs, Chinese Herbal; Endothelial Cells; Humans; Hydrogen Peroxide; Oxidative Stress; Phenanthrolines; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Salvia miltiorrhiza | 2012 |